Finance

Lists
KAPA:NYSEAMERICAN
Kairos Pharma Ltd
1,68 USD
0,00%
(0,00) 1D
29-сен., 14:49:55 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KAPA...
Open
1,68 USD
High
1,76 USD
Low
1,64 USD
Mkt. cap
5,69 млн
Avg. vol.
245,44 миң
Volume
41,03 миң
52-wk high
9,59 USD
52-wk low
1,51 USD
EPS
-1,95 USD
Shares outstanding
3,38 млн
No. of employees
3
Open
1,68 USD
High
1,76 USD
Low
1,64 USD
Mkt. cap
5,69 млн
Avg. vol.
245,44 миң
Volume
41,03 миң
52-wk high
9,59 USD
52-wk low
1,51 USD
EPS
-1,95 USD
Shares outstanding
3,38 млн
No. of employees
3
About Kairos Pharma Ltd
CEO-
Employees3
Founded2013
HeadquartersЛос Анджелес, Калифорния, Америка Кошмо Штаттары
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
608,00 миң
538,00 миң
684,00 миң
619,00 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
827,00 миң
877,00 миң
1,01 млн
798,00 миң
Operating expense
1,44 млн
1,42 млн
1,69 млн
1,42 млн
Total operating expenses
1,44 млн
1,42 млн
1,69 млн
1,42 млн
Operating income
-1,44 млн
-1,42 млн
-1,69 млн
-1,42 млн
Other non operating income
-
-
-
-
EBT including unusual items
-1,40 млн
-1,36 млн
-1,65 млн
-1,39 млн
EBT excluding unusual items
-1,40 млн
-1,36 млн
-1,65 млн
-1,39 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,40 млн
-1,36 млн
-1,65 млн
-1,39 млн
Net profit margin
-
-
-
-
Earnings per share
-0,49
-0,49
-0,56
-0,42
Interest and investment income
37,00 миң
50,00 миң
36,00 миң
29,00 миң
Interest expense
-
-
-
-
Net interest expenses
37,00 миң
50,00 миң
36,00 миң
29,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,40 млн
-1,38 млн
-1,65 млн
-1,40 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору